JAMES C. BLAIR

Profile

First Name

: JAMES

Middle Name

: C.

Last Name

: BLAIR

Related Companies
Titles
Company Name
Related People
DIRECTOR
ZOGENIX INC
LOUIS C. BOCK, STEPHEN J. FARR, CAM GARNER, CAM L. GARNER, KEN HAAS, J.D. HALDEMAN, ROGER L. HAWLEY, ERLE T. MAST, ARDA M. MINOCHERHOMJEE, ARDA M. MINOCHERHOMJEE, PH.D., DAVID W. NASSIF, ANN D. RHOADS, CYNTHIA Y. ROBINSON, KURT C. WHEELER, ALEX ZISSON
EXECUTIVE OFFICER
DP VIII ASSOCIATES, L.P.
BRIAN H. DOVEY, BRIAN K. HALAK, KATHLEEN K. SCHOEMAKER, JESSE I. TREU, NICOLE VITULLO
EXECUTIVE OFFICER
DOMAIN PARTNERS VIII, L.P.
BRIAN H. DOVEY, BRIAN K. HALAK, KATHLEEN K. SCHOEMAKER, JESSE I. TREU, NICOLE VITULLO
DIRECTOR
INTEGENX INC
DAVID BARKER, RONALD W. EASTMAN, LOUIS GREVER, DENNIS HARRIS, STEVAN JOVANOVICH, DONG-SU KIM, ANDRE MARION, MOSTAFA RONAGHI, BENJAMIN S. SCHAPIRO, DAVID SMITH, JAMES N. WOODY, M.D., PH.D
DIRECTOR
APPLIED PROTEOMICS, INC.
DANIEL ABRUTYN, DAVID AGUS, JAMES BLAIR, DANIEL HILLIS, ERIK HOLMLIN, PETER KLEMM, KOK THAY LIM
DIRECTOR
CLOVIS ONCOLOGY, INC.
ANDREW R. ALLEN, BRIAN G. ATWOOD, M. JAMES BARRET, KEITH FLAHERTY, GINGER L. GRAHAM, STEVEN L. HOERTER, GILLIAN C. IVERS-READ, PAUL KLINGENSTEIN, PATRICK J. MAHAFFY, ERLE T. MAST, EDWARD J. MCKINLEY, THORLEF SPICKSCHEN
EXECUTIVE OFFICER
DOMAIN PARTNERS IX, L.P.
BRIAN H. DOVEY, BRIAN K. HALAK, KIM KAMDAR, KATHLEEN K. SCHOEMAKER, NIMESH SHAH, NICOLE VITULLO
DIRECTOR
ATYR PHARMA INC
SRINI AKKARAJU, JOHN T. BLAKE, FREDERIC CHEREAU, JOHN K. CLARKE, TIMOTHY P. COUGHLIN, KATHRYN FALBERG, MARK GOLDBERG, JEFFREY S. HATFIELD, NANCY D. KRUEGER, JOHN D. MENDLEIN, AMIR NASHAT, AMIR H. NASHAT, SC.D., ED PENHOET, SANUJ K. RAVINDRAN, PAUL SCHIMMEL, SANJAY S. SHUKLA, AKKARAJU SRINIVAS, DAVID WEINER
EXECUTIVE OFFICER, DIRECTOR
GENE SCIENCES, INC.
JAMES T. DEMETRIADES, PETER DERVAN, LYNNE ROLLINS
DIRECTOR
AXIAL BIOTHERAPEUTICS, INC.
RICHARD P. ALDRICH, SAKAE ASANUMA, SCOTT C. BRUN, A. STEWART CAMPBELL, MICHELE CUCULLU, ERIC DE LA FORTELLE, MICHELLE DIPP, DAVID H. DONABEDIAN, NORA FREY, SARKIS K. MAZMANIAN, SARAH MEIBUSCH, MARK OHORI, RONALD C. RENAUD JR., REBECCA SENTER, HENRY C. WOLF, JEFFREY YOUNG, JEFFREY E. YOUNG
DIRECTOR
CHROMACODE, INC.
PATRICK BALTHROP, ALEXANDER G. DICKINSON, PAUL FLOOK, CAROL GALLAGHER, GREGORY J. GOSCH, JUSTIN KLEIN, PETER JUSTIN KLEIN, VIKRAM LAMBDA, CHRISTOPHER MACGRIFF, MARK MCDONOUGH, KEVIN O-BOYLE, ADITYA RAJAGOPAL, LYNNE ROLLINS, AXEL SCHERER, PAT SMERKERS, JENNY YIP
DIRECTOR
AXIAL THERAPEUTICS, INC.
RICHARD P. ALDRICH, SAKAE ASANUMA, SCOTT C. BRUN, A. STEWART CAMPBELL, MICHELE CUCULLU, ERIC DE LA FORTELLE, MICHELLE DIPP, DAVID H. DONABEDIAN, NORA FREY, SARKIS K. MAZMANIAN, SARAH MEIBUSCH, MARK OHORI, RONALD C. RENAUD JR., REBECCA SENTER, HENRY C. WOLF, JEFFREY YOUNG, JEFFREY E. YOUNG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-10-18 
2022-03-03
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2022-02-28 
2021-10-25
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-05-11 
2021-05-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-11 
2020-12-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2020-05-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-07 
2019-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-06-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-18 
2019-04-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
2018-11-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2017-09-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-08-31 
2017-06-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
2017-04-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-17 
2016-12-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
2016-12-07
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-15 
2016-11-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-10 
2015-12-03
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-15 
2015-04-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-03-31 
2014-12-24
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-12-15 
2013-11-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-11-19 
2012-12-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-10-26 
2012-08-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-10-26 
2012-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-07 
2011-11-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-10-26 
2011-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-31 
2010-07-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-07-01 
2009-12-15
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-10-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-07-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-07-17 
2009-06-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-06-15 
2009-06-18
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2009-06-04 
2009-06-10
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2009-05-26 
2009-05-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-05-15